Home › Multiple Myeloma › New Jersey › Clifton
Multiple Myeloma clinical trials in Clifton, NJ
14 studies for Multiple Myeloma are looking for participants at sites in and around Clifton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
RecruitingPhase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi away
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RecruitingPhase 4
- Hackensack University Medical Center, Hackensack · 7 mi away
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
RecruitingPhase 1
- Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 7 mi away
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
RecruitingPhase 2
- John Theurer Cancer Center, Hackensack · 7 mi away
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecruitingPhase 3
- Hackensack Meridian Health, Hackensack · 7 mi away
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
RecruitingPhase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi away
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RecruitingPhase 1
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi away
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1/2
- Research Site, Hackensack · 7 mi away
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
RecruitingPhase 1
- Hackensack University Medical Center, Hackensack · 7 mi away
Mosaic Trial for Stem Cell Transplant Recipients
Recruiting
- Hackensack Meridian Health, Nutley · 3 mi away
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
RecruitingPhase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RecruitingPhase 3
- GSK Investigational Site, Hackensack · 7 mi away
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
RecruitingPhase 1
- Hackensack Meridian John Theurer Cancer Center, Hackensack · 7 mi away
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1/2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Other studies in Clifton
- Non-Small Cell Lung Cancer24 studies
- Cancer (all types)15 studies
- Metastatic Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Breast Cancer12 studies
- Ovarian Cancer11 studies
- Lung Cancer10 studies
- Endometrial Cancer8 studies
- Triple-Negative Breast Cancer8 studies
- Colorectal Cancer8 studies
- Head and Neck Squamous Cell Carcinoma8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.